NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons

By sjmartinez • January 23, 2024

King AJ, Chang L, Li Q, Liu L, Zhu Y, Pasricha PJ, Wang J, Siegel M, Caldwell JS, Edelstein S, Rosenbaum DP, Kozuka K. NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons. Am J Physiol Gastrointest Liver Physiol. 2024 Jan 22. doi: 10.1152/ajpgi.00233.2023. Epub ahead of print. PMID: 38252683.

Tags: Digestive Diseases, dorsal root ganglia neurons, intestinal barrier permeability, Publications, Tenapanor, TRPV1, visceral hypersensitivity

Related Posts

The 2024 top 10 list of endoscopy topics in medical publishing: an annual review by the American Society for Gastrointestinal Endoscopy Editorial Board

Martinez M, Bartel MJ, Chua T, Dakhoul L, Fatima H, Glessing B, Jensen D, Lara LF, Shinn B, Tadros M, Villa E, Saltzman JR. The[...]

Fidaxomicin reduces collagen expression in intestinal fibroblasts via platelet-derived growth factor receptor beta and glycogen synthase kinase-3 beta inhibition

Irwin S, van Daelen M, Almaraz I, Park R, Nelson B, Mahurkar-Joshi S, Rieder F, Shih DQ, Ho W, Limketkai B, Koon HW. Fidaxomicin reduces[...]

Social Determinants of Health are Associated with Liver Transplant Evaluation and Listing in a Safety-Net Referral Cohort

Bangaru S, Wang MC, Sumethasorn M, Wang S, Wong C, Omer S, Kim N, Shah S, Yilma M, Tana M, Mehta N, Benhammou JN, Zhou[...]